Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
J Infect. 2021 Nov;83(5):607-635. doi: 10.1016/j.jinf.2021.08.010. Epub 2021 Aug 9.
J Infect. 2021.
PMID: 34384810
Free PMC article.